Trial Profile
Besifloxacin Ophthalmic Suspension in Patients With Bacterial Keratitis: A Prospective, Randomized Clinical Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2023
Price :
$35
*
At a glance
- Drugs Besifloxacin (Primary) ; Cefazolin; Tobramycin
- Indications Keratitis
- Focus Therapeutic Use
- 17 Oct 2023 Status changed from recruiting to completed.
- 14 Sep 2016 Status changed from not yet recruiting to recruiting.
- 17 Jul 2015 New trial record